Pharvaris Company Contacts

Pharvaris

https://pharvaris.com
Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and... Read More
Contacts

Country

Switzerland

City

Zug

Headquarters

Zug, CH

Profile

Founded

2015

Industry

Pharmaceutical Manufacturing

Size

51 - 200

Specialties

Medicinal Chemistry, Hereditary Angioedema, Drug Discovery, Drug Development, Biotechnology, Pharmaceuticals

Funding

Total Rounds

5

Last Round

Tue Dec 05 2023

Last Round Series

Post IPO equity

Last Round Raised

$ 300,000,000